In Conversation With… Professor Ailsa Hart
“We have to make the case that avoiding steroids isn’t just about following guidelines - it’s about protecting the long-term health of our patients.” Steroids remain a cornerstone of inflammatory ...
Measuring What Matters: Steroid-toxicity and Patient Outcomes
Ten years ago, two clinical researchers walked into a bar and, over a beer, asked themselves whether the direct measurement of steroid-toxicity would ever be possible. Today, Steritas, in licensing ...
In Conversation With… Tonya Winders
"For more than 20 years, we've had monoclonal antibodies for asthma, yet only one in five eligible patients are on them. And in more than 80 countries, there isn’t a single biologic available." The ...
The Trials Driving the Next Wave of Steroid-Sparing Innovation
A wave of clinical trial results using the STOX® Suite of clinical outcome assessments (COAs) in a range of diseases will soon reach the shore, helping to deliver new therapeutic options for ...
In Conversation With… Joyce Kullman
“Imagine how many lives could be saved if we spent as much energy on rare disease awareness and education as we do on celebrity culture.” Patient advocacy groups (PAGs) are critical in bridging the ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
